ZIVO BIOSCIENCE INC (ZIVO)
ZIVO moved a median of 0.00% 30 minutes after news, and 0.00% by the close. How ZIVO actually reacts to news — the realized, point-in-time move the market made, measured across 122 labeled events over the last three years with zero look-ahead.
ZIVO’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | 0.00% | 20% | 89 |
| 30-min | 0.00% | 29% | 94 |
| 60-min | 0.00% | 30% | 96 |
| to close | 0.00% | 39% | 98 |
| Middle 50% of ZIVO reactions | -0.10% to +0.53% |
|---|---|
| Median reaction (30-min) | 0.00% |
| Measured reactions | 122 |
Half of all ZIVO BIOSCIENCE INC news events land between -0.10% and +0.53% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
Email me when ZIVO moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to ZIVO's baseline. Nothing else.
Recent ZIVO events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Zivo Bioscience, Inc. Announces Transition to OTCID Marketplace | Press release | Business Wire | — | -9.47% | |
| ZIVO Bioscience Secures Commercial-Scale Manufacturing Agreement with Cyanotech Corporation for Zivolife™ Algal Biomass | Press release | Business Wire | +0.20% | -2.98% | |
| Form EFFECT Zivo Bioscience, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +0.00% | -26.15% | |
| Form 15-12G Zivo Bioscience, Inc. | SEC filing · Form 15-12G | SEC EDGAR | -8.00% | +35.00% | |
| Form POS AM Zivo Bioscience, Inc. | SEC filing · Form POS | SEC EDGAR | -8.00% | +35.00% | |
| Form S-8 POS Zivo Bioscience, Inc. | SEC filing · Form S-8 | SEC EDGAR | -8.00% | +35.00% | |
| Form 8-K Zivo Bioscience, Inc. For: Mar 26 | SEC filing · Form 8-K | SEC EDGAR | -9.62% | +3.21% | |
| ZIVO Bioscience Provides Special Letter to Shareholders | Press release | Business Wire | -9.62% | +3.21% | |
| Form 8-K Zivo Bioscience, Inc. For: Dec 19 | SEC filing · Form 8-K | SEC EDGAR | -0.67% | -21.82% | |
| Form 10-Q Zivo Bioscience, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Zivo Bioscience, Inc. For: Sep 10 | SEC filing · Form 8-K | SEC EDGAR | — | +0.36% | |
| ZIVO Bioscience CEO Letter to Shareholders Highlights Progress with Human Nutrition and Animal Therapeutic Businesses | Press release | Business Wire | +0.00% | -3.38% | |
| Form 8-K Zivo Bioscience, Inc. For: Aug 12 | SEC filing · Form 8-K | SEC EDGAR | +9.17% | — | |
| Form 10-Q Zivo Bioscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Zivo Bioscience, Inc. For: Jul 08 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| ZIVO Bioscience and Leading Global Animal Health Company to Advance ZIVO’s Immune-Enhancing Compounds in Poultry | Press release | Business Wire | — | — | |
| Form 8-K Zivo Bioscience, Inc. For: Jun 09 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 10-Q Zivo Bioscience, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| University of Delaware Study Identifies Optimal Formulation of ZIVO’s Active Ingredients for Further Testing to Mitigate Avian Influenza in Poultry | Press release | Business Wire | — | — | |
| Form ARS Zivo Bioscience, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.00% | -5.98% | |
| Form DEF 14A Zivo Bioscience, Inc. For: Apr 25 | SEC filing · Form DEF | SEC EDGAR | — | — | |
| Form DEFA14A Zivo Bioscience, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -5.98% | |
| Form 10-K Zivo Bioscience, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +0.00% | |
| ZIVO Bioscience Plans New Study with University of Delaware to Combat Avian Influenza in Poultry | Press release | Business Wire | +0.00% | +0.00% | |
| Form 8-K Zivo Bioscience, Inc. For: Jan 22 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.95% | |
| ZIVO Bioscience to Present at The Microcap Conference 2025 | Press release | Business Wire | +4.64% | +3.47% | |
| Form 8-K Zivo Bioscience, Inc. For: Jan 09 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Zivo Bioscience, Inc. For: Jan 07 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.33% | |
| ZIVO Bioscience Reports Progress with Coccidiosis Treatment Licensing Opportunities | Press release | Business Wire | +0.00% | +19.46% | |
| ZIVO Bioscience Reports Preliminary Efficacy of its Proprietary Active Ingredients in the Battle Against Avian Influenza | Press release | Business Wire | +0.03% | +8.31% | |
| Form 8-K Zivo Bioscience, Inc. For: Nov 12 | SEC filing · Form 8-K | SEC EDGAR | -0.05% | -0.05% | |
| Form 10-Q Zivo Bioscience, Inc. For: Sep 30 | SEC filing · Form 10-Q | SEC EDGAR | -0.05% | -0.05% | |
| Form 8-K Zivo Bioscience, Inc. For: Oct 17 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.56% | |
| ZIVO Reports Favorable Results from 42-Day Confirmatory Study of its Coccidiosis Treatment in Broiler Chickens | Press release | Business Wire | -1.14% | +7.14% | |
| Form 10-Q Zivo Bioscience, Inc. For: Jun 30 | SEC filing · Form 10-Q | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Zivo Bioscience, Inc. For: Jul 11 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Major Global Animal Health Company Launches 42-Day Confirmatory Study with ZIVO Bioscience’s Coccidiosis Treatment in Broiler Chickens | Press release | Business Wire | +17.13% | -6.25% | |
| Form 8-K Zivo Bioscience, Inc. For: Jun 11 | SEC filing · Form 8-K | SEC EDGAR | — | — | |
| Form 8-K/A Zivo Bioscience, Inc. For: Jun 06 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 8-K Zivo Bioscience, Inc. For: May 31 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Form 10-Q Zivo Bioscience, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | — | — | |
| Form ARS Zivo Bioscience, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | — | +0.00% | |
| Form DEF 14A Zivo Bioscience, Inc. For: Jun 11 | SEC filing · Form DEF | SEC EDGAR | +0.00% | +15.71% | |
| Form DEFA14A Zivo Bioscience, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | +15.71% | |
| Form 10-K Zivo Bioscience, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | +0.00% | +7.91% | |
| Form 8-K Zivo Bioscience, Inc. For: Feb 13 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.78% | |
| ZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge Study | Press release | Business Wire | +9.62% | +1.00% | |
| ZIVO Bioscience Announces Uplisting to OTCQB Market | Press release | Business Wire | -5.37% | +6.77% | |
| ZIVO Bioscience Reports Positive Efficacy Results from 42-Day Validation Study with Non-Antibiotic Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler Chickens | Press release | Business Wire | +6.54% | +13.08% | |
| Form 8-K Zivo Bioscience, Inc. For: Dec 05 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +1.35% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the ZIVO section they belong to.
Where else ZIVO is measured.
ZIVO earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| EISAI CO LTD (ESALF) | 122 | 0.00% | 7% |
| WAYLAND GROUP CORP ORD (MRRCF) | 122 | -0.44% | 40% |
| American Shared Hospital Services (AMS) | 121 | 0.00% | 48% |
| Protagenic Therapeutics, Inc. (PTIX) | 121 | 0.00% | 39% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is ZIVO BIOSCIENCE INC's median reaction calculated?
Every labeled ZIVO news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 122 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 29% of ZIVO's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does ZIVO's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.